Background and Objective: Evidence indicates that migration to Western countries is associated with increased metabolic syndrome (MetS) risk. There is, however, a scarcity of data about MetS incidence in migrants to Middle Eastern countries. This study aimed to investigate the relationship between migration and the incidence of MetS following a 24-months residency in Qatar. Method: Following the necessary ethics approvals, migrants to Qatar aged 18–65 years were invited to participate. Baseline screening for MetS parameters included glycated haemoglobin, triglycerides, high-density lipoprotein-cholesterol, blood pressure, and waist circumference. Migrants with normal metabolic parameters were invited for rescreening 24-months post-migration and, parameters repeated. Those with abnormal metabolic parameters were counselled or referred for medical review and excluded from follow up. Main outcome measures: The incidence of metabolic syndrome amongst initially metabolic syndrome-free moigratns, 24-months post migration. The determinants of MetS andMetS elements among Qatar migrants, 24 months post migration. Results: Four hundred seventy-two consented to participate of 1379 identified. 205 (43.4%) migrants had normal metabolic parameters at baseline and were recalled 24 months post-migration, with 160 completing follow-up. The incidence of MetS within this group rose to 17% (n=27/160, 95% CI; 11.0%–23.0%) and 81% (n=129/160) developed at least one element of MetS following 24 months in Qatar. Conclusion: Migration to Qatar was associated with the development of MetS after 24 months of migration. Further studies are required to determine the risk factors and the predictors of MetS amongst migrants to Qatar.
AL-ADAWI, R., PRABHU, K.S., RYAN, C., ABDELAZIZ, H., EL EDRISI, M. and IBRAHIM, M.I.M. 2021. The incidence of metabolic syndrome amongst Qatar migrants 24 month post-migration: a prospective longiudinal observational cohort study. Presented at 49th ESCP (European Society of Clinical Pharmacy) virtual symposium on clinical pharmacy (ESCP 2021): clinical pharmacy, working collaboratively in mental health care, 19-21 October 2021, [virtual conference].